Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes.

Adham, Sirin A; Szewczuk, Myron R; Mraiche, Fatima; Petricoin, Emanuel

Adham, Sirin A; Szewczuk, Myron R; Mraiche, Fatima; Petricoin, Emanuel.

Afiliación

Adham SA; Department of Biology, College of Science, Sultan Qaboos University, Muscat, Oman.
Szewczuk MR; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Mraiche F; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Petricoin E; Institute for Biomedical Innovation, George Mason University, Manassas, VA, United States.

Front Oncol ; 12: 1100427, 2022.

Article en En | MEDLINE | ID: mdl-36582793

Palabras clave

TNBC; breast cancer; cardiotoxicity; conservative breast therapy; neoadjuvant chemotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Omán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google